Palapas, Maurine .
HRN: 26-20-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
CEFUROXIME 750MG (VIAL)
11/15/2024
11/21/2024
IV
750mg
Q8H
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes